18.10.2013 21:18:00

Moody's affirms Excelitas' B3 CFR on Qioptiq acquisition and refinancing; outlook changed to negative from stable

Assigns B1 rating to company's proposed 1st lien facilities

Vollständigen Artikel bei Moodys lesen